BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 15722626)

  • 21. Peritonectomy and hyperthermic antiblastic perfusion in the treatment of peritoneal carcinomatosis.
    Cavaliere F; Di Filippo F; Botti C; Cosimelli M; Giannarelli D; Aloe L; Arcuri E; Aromatario C; Consolo S; Callopoli A; Laurenzi L; Tedesco M; Di Angelo P; Giunta S; Cavaliere R
    Eur J Surg Oncol; 2000 Aug; 26(5):486-91. PubMed ID: 11016471
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatic vascular isolation and perfusion for patients with progressive unresectable liver metastases from colorectal carcinoma refractory to previous systemic and regional chemotherapy.
    Alexander HR; Libutti SK; Bartlett DL; Pingpank JF; Kranda K; Helsabeck C; Beresnev T
    Cancer; 2002 Aug; 95(4):730-6. PubMed ID: 12209715
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prospective randomized clinical trial of two drug delivery pathway in the treatment of inoperable advanced pancreatic carcinoma.
    Han GH; Yin ZX; Meng XJ; He CY; Zhang HB; Sun AH; Wu KC; Ding J; Fan DM
    Chin J Dig Dis; 2006; 7(1):45-8. PubMed ID: 16412037
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytoreductive surgery plus intraperitoneal hyperthermic perfusion is an effective treatment for metastasized malignant mixed mesodermal tumours (MMMT)--report of six cases.
    Müller H; Nakchbandi V
    Eur J Surg Oncol; 2004 Jun; 30(5):573-7. PubMed ID: 15135489
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regional chemotherapy with hemofiltration: a rationale for a different treatment approach to advanced pancreatic cancer.
    Muchmore JH; Carter RD; Preslan JE; George WJ
    Hepatogastroenterology; 1996; 43(8):346-55. PubMed ID: 8714227
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of anthracyclines and paclitaxel as first line chemotherapy in patients with visceral metastases of breast cancer.
    Rossi D; Graziano F; Luzi Fedeli S; Fedeli A; Alessandroni P; Catalano V; Giordani P; Testa E; Catalano G
    Minerva Med; 2002 Aug; 93(4):303-7. PubMed ID: 12207200
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Results of intraperitoneal active charcoal-mitomycin C therapy of stomach carcinoma with serosa invasion].
    Fass J; Jansen M; Zengel K; Reinecke T; Asshoff G; Schumpelick V
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():1363-6. PubMed ID: 9931883
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stop-flow perfusion with mitomycin-C as locoregional approach in the treatment of large-unresectable liver metastases.
    Gadaleta C; Catino A; Mattioli V
    In Vivo; 2006; 20(6A):769-71. PubMed ID: 17203765
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regional chemotherapy for inoperable pancreatic carcinoma.
    Muchmore JH; Preslan JE; George WJ
    Cancer; 1996 Aug; 78(3 Suppl):664-73. PubMed ID: 8681305
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adjuvant regional chemotherapy in advanced pancreatic cancer: results of a prospective study.
    Beger HG; Link KH; Gansauge F
    Hepatogastroenterology; 1998; 45(21):638-43. PubMed ID: 9684109
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prospective randomized trial of 5-fluorouracil, doxorubicin, and mitomycin C for non-resectable pancreatic and biliary carcinoma: multicenter randomized trial.
    Takada T; Nimura Y; Katoh H; Nagakawa T; Nakayama T; Matsushiro T; Amano H; Wada K
    Hepatogastroenterology; 1998; 45(24):2020-6. PubMed ID: 9951857
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Isolated hypoxic perfusion with mitomycin C confers no benefit for patients with advanced pancreatic carcinoma].
    Petrowsky H; Heinrich S; Staib-Sebler E; Gog C; Janshon G; Lorenz M
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():1351-3. PubMed ID: 9931879
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel arterial infusion chemotherapy for the treatment of patients with advanced pancreatic carcinoma after vascular supply distribution via superselective embolization.
    Homma H; Doi T; Mezawa S; Takada K; Kukitsu T; Oku T; Akiyama T; Kusakabe T; Miyanishi K; Niitsu Y
    Cancer; 2000 Jul; 89(2):303-13. PubMed ID: 10918160
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hyperthermic intra-peritoneal chemotherapy (HIPEC) in patients with peritoneal pseudomyxoma or peritoneal metastases of colorectal carcinoma; good preliminary results from the Netherlands Cancer Institute].
    Zoetmulder FA; van der Vange N; Witkamp AJ; Kaag MM; Boot H; Beijnen JH
    Ned Tijdschr Geneeskd; 1999 Sep; 143(37):1863-8. PubMed ID: 10526600
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phase I/II trial of intraperitoneal 5-Fluorouracil with and without intravenous vasopressin in non-resectable pancreas cancer.
    Oman M; Lundqvist S; Gustavsson B; Hafström LO; Naredi P
    Cancer Chemother Pharmacol; 2005 Dec; 56(6):603-9. PubMed ID: 16047145
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of intraperitoneal mitomycin C.
    van Ruth S; Verwaal VJ; Zoetmulder FA
    Surg Oncol Clin N Am; 2003 Jul; 12(3):771-80. PubMed ID: 14567030
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypoxic stop-flow perfusion with mitomycin-C in the treatment of multifocal liver metastases. Usefulness of a vascular arterial stent to prevent iatrogenic lesions of the hepatic arterial wall.
    Gadaleta CD; Catino A; Ranieri G; Armenise F; Console G; Mattioli V
    J Exp Clin Cancer Res; 2003 Dec; 22(4 Suppl):203-6. PubMed ID: 16767932
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mitomycin C hypoxic pelvic perfusion for unresectable recurrent rectal cancer: pharmacokinetic comparison of surgical and percutaneous techniques.
    Guadagni S; Fiorentini G; Clementi M; Palumbo P; Mambrini A; Masedu F
    Updates Surg; 2017 Sep; 69(3):403-410. PubMed ID: 28791628
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-dose mitomycin C in isolated hyperthermic liver perfusion for unresectable liver metastases.
    Oldhafer KJ; Frerker MK; Lang H; Fauler J; Flemming P; Schmoll E; Nadalin S; Moreno L; Pichlmayr R
    J Invest Surg; 1998; 11(6):393-400. PubMed ID: 9895113
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of hyperthermia on pharmacokinetics of intraperitoneal mitomycin C in rats investigated by microdialysis.
    Sørensen O; Andersen AM; Kristian A; Giercksky KE; Flatmark K
    J Surg Oncol; 2014 May; 109(6):521-6. PubMed ID: 24347444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.